AnaptysBio Inc (ANAB)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO, CA 92121

AnaptysBio, Inc. operates as a clinical stage biotechnology company. The Company manufactures and markets antibodies for cancer immunotherapy and inflammation. AnaptysBio has primary operations in the United States.

Data based on most recent fiscal year report
Market Cap2.116 Billion Shares Outstanding23.5 Million Avg Volume390.414 Thousand
1-Yr BETA vs S&P TR1.53 Current Ratio17.93 Quick Ratio17.93
View SEC Filings from ANAB instead.
Q2 2019 All Institutions Hedge Funds 1
To trade ANAB now:
Filers who had this stock in their top 10: 1 0 (0.0%)
13F Filers holding this stock: 126 24 (2.48%)
Aggregate 13F shares on 06/30/2019: 29.977 Million 7.652 Million
Aggregate 13F shares on 03/31/2019: 28.964 Million 7.601 Million
Percent change: 3.50% 0.67%
Funds creating new positions: 23 5
Funds Adding to an existing position: 58 10
Funds closing out their position: 22 5
Funds reducing their position: 24 6
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ANAB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TOPPER JAMES N

  • Director
0 2019-09-30 1

HAMILL LAURA

  • Director
0 2019-09-24 2

SCHOENECK JAMES A INTERIM CEO

  • Officer
  • Director
103,700 2019-09-18 0

LYDON NICHOLAS

  • Director
107,727 2019-08-19 1

LOUMEAU ERIC J GENERAL COUNSEL & INTERIM CFO

  • Officer
0 2019-08-18 2

RENTON HOLLINGS

  • Director
16,020 2019-08-08 1

GALLAGHER CAROL GILTNER

  • Director
0 2019-07-24 0

NOVO HOLDINGS A/S

  • 10% Owner
2,927,560 2019-07-23 0

SCHMID JOHN P.

  • Director
0 2019-06-13 1

FENTON DENNIS M

  • Director
13,194 2019-06-13 1

SURIA HAMZA PRESIDENT, CEO

  • Officer
  • Director
17,636 2019-06-10 6

LONDEI MARCO CHIEF MEDICAL OFFICER

  • Officer
22,377 2019-06-04 4

PISCITELLI DOMINIC CHIEF FINANCIAL OFFICER

  • Officer
0 2019-02-08 2

WARE J. ANTHONY

  • Director
0 2019-02-08 1

FRAZIER HEALTHCARE VII, L.P.

FRAZIER HEALTHCARE VII-A, L.P.

FHM VII, L.P.

FHM VII, L.L.C.

FRAZIER ALAN D

NAINI NADER J

EVERY NATHAN R

HERON PATRICK J

  • 10% Owner
No longer subject to file 2018-05-11 0

FRAZIER HEALTHCARE V, LP

FHM V, LP

FHM V, LLC

FRAZIER ALAN D

NAINI NADER J

EVERY NATHAN R

HERON PATRICK J

  • 10% Owner
No longer subject to file 2018-05-11 0

AVALON VENTURES VII L P

AVALON VENTURES VII GP, LLC

KINSELLA KEVIN J

TOMLIN STEPHEN LAWRENCE

  • 10% Owner
  • SEE REMARKSSEE REMARKSSEE REMARKS
No longer subject to file 2017-07-26 0

MOYLE MATTHEW CHIEF SCIENTIFIC OFFICER

  • Officer
0 2017-02-24 0

AVALON VENTURES VII L P

KINSELLA KEVIN J

TOMLIN STEPHEN LAWRENCE

  • 10% Owner
2,036,932 2017-01-25 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

HAMILL LAURA - Director

2019-09-24 A 2,268 a 2,268 0.00 direct

HAMILL LAURA - Director

2019-09-24 A 6,000 a 6,000 0.00 direct

LOUMEAU ERIC J - Officer GENERAL COUNSEL & INTERIM CFO

2019-08-18 A 17,500 a 17,500 0.00 direct

**EXPERIMENTAL** Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin
PDT Partners, LLC AnaptysBio, Inc. 0.59% 2018-02-07 GERMANY

Short Position History

Holder Net Short Position Position Date Origin
PDT Partners, LLC AnaptysBio, Inc. 0.68% 2018-01-25 GERMANY
PDT Partners, LLC AnaptysBio, Inc. 0.7% 2018-01-24 GERMANY
Click here to report any possible errors with this stock listing.

Elevate your investments